Shares of 4D Pharma Plc (LON: DDDD) today surged 10.2% higher as the company hosted an R&D webinar on the science behind its Live Biotherapeutic drug discovery engine, MicroRx®.
The webinar was presented by the firm’s Research Director, Dr Imke Mulder and covered topics on MicroRx® including why the company’s focus on the mechanism of single-strain LBPs drives a rational drug discovery approach and guides effective development.
Neurodegenerative diseases and 4D pharma candidates – MRx0029 and MRx0005 as well as MRx0518, oncology and the MicroRx platform were also discussed at length during the webinar.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
The webinar also delved into how the MicroRx platform investigates functionality and its proprietary culture collection methods.
This was a detailed webinar that demonstrated the significant potential behind the MicroRx® triggering the surge in 4D Pharma’s stock price.
Investors were impressed by the significant progress made by 4D Pharma in developing its research candidates and the role of the MicroRx® during the entire process.
4D Pharma share price
Source: Tradingview
4D Pharma shares today rallied 10.2% higher to trade at 108p having risen from Friday’s closing price of 98p.
- 4D Pharma shares consistently fell in the past
- Trade stocks with the highly-rated IG UK
- Find alternative brokers to Hargreaves Lansdown